Clinical Trial Update: Study of RO7515629 in Participants With HLA-G Positive Solid Tumors [Phase 1]

View source ↗

Summary

This Phase 1 study of RO7515629 in participants with HLA-G positive solid tumors has been terminated. The trial enrolled patients with renal cell carcinoma, non…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Non-small Cell Lung Cancer
• Ovarian Cancer
• Pancreatic Adenocarcinoma
• Renal Cell Carcinoma

Drugs mentioned

• RO7515629

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Renal Cell Carcinoma, Non-small Cell Lung Cancer | Phase 1 | Status: TERMINATED